dc.contributor.author | Jackson, Sarah S. | |
dc.contributor.author | Pfeiffer, Ruth | |
dc.contributor.author | Gabbi, Chiara | |
dc.contributor.author | Anderson, Lesley | |
dc.contributor.author | Gadalla, Shahinaz M. | |
dc.contributor.author | Koshiol, Jill | |
dc.date.accessioned | 2022-11-10T00:09:01Z | |
dc.date.available | 2022-11-10T00:09:01Z | |
dc.date.issued | 2022-02 | |
dc.identifier | 201450898 | |
dc.identifier | 7de593b1-0990-49fb-9455-b94bee84e35f | |
dc.identifier | 85123314536 | |
dc.identifier | 34766362 | |
dc.identifier | 000743291300014 | |
dc.identifier.citation | Jackson , S S , Pfeiffer , R , Gabbi , C , Anderson , L , Gadalla , S M & Koshiol , J 2022 , ' Menopausal hormone therapy and risk of biliary tract cancers ' , Hepatology , vol. 75 , no. 2 , pp. 309-321 . https://doi.org/10.1002/hep.32198 | en |
dc.identifier.issn | 0270-9139 | |
dc.identifier.other | ORCID: /0000-0002-1000-3649/work/110275538 | |
dc.identifier.uri | http://aura-test.abdn.ac.uk/handle/2164/19271 | |
dc.description | Funding: Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics. The funders had no role in the conduct of this research. | en |
dc.format.extent | 13 | |
dc.format.extent | 478739 | |
dc.format.extent | 290333 | |
dc.language.iso | eng | |
dc.relation.ispartof | Hepatology | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | Menopausal hormone therapy | en |
dc.subject | biliary tract cancer | en |
dc.subject | gallbladder cancer | en |
dc.subject | cholangiocarcinoma | en |
dc.subject | Suppositories | en |
dc.subject | Progestins/therapeutic use | en |
dc.subject | Cholangiocarcinoma/epidemiology | en |
dc.subject | Humans | en |
dc.subject | Menopause | en |
dc.subject | Middle Aged | en |
dc.subject | Common Bile Duct Neoplasms/epidemiology | en |
dc.subject | Ampulla of Vater | en |
dc.subject | Case-Control Studies | en |
dc.subject | Hormone Replacement Therapy | en |
dc.subject | Incidence | en |
dc.subject | Gallbladder Neoplasms/epidemiology | en |
dc.subject | Progesterone/therapeutic use | en |
dc.subject | Aged, 80 and over | en |
dc.subject | Estrogens/therapeutic use | en |
dc.subject | Female | en |
dc.subject | Administration, Oral | en |
dc.subject | Risk Factors | en |
dc.subject | United Kingdom/epidemiology | en |
dc.subject | Aged | en |
dc.subject | Administration, Topical | en |
dc.subject | Drug Combinations | en |
dc.subject | Neoplasms, Complex and Mixed/epidemiology | en |
dc.subject | CHOLANGIOCARCINOMA | en |
dc.subject | HUMAN FEMALE | en |
dc.subject | PREGNANCY | en |
dc.subject | REPLACEMENT | en |
dc.subject | WOMEN | en |
dc.subject | GALLBLADDER FUNCTION | en |
dc.subject | DISEASE | en |
dc.subject | ESTROGEN | en |
dc.subject | REPRODUCTIVE FACTORS | en |
dc.subject | EPIDEMIOLOGY | en |
dc.subject | R Medicine | en |
dc.subject | Hepatology | en |
dc.subject.lcc | R | en |
dc.title | Menopausal hormone therapy and risk of biliary tract cancers | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | https://doi.org/10.1002/hep.32198 | |
dc.date.embargoedUntil | 2022-10-04 | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85123314536&partnerID=8YFLogxK | en |
dc.identifier.vol | 75 | en |
dc.identifier.iss | 2 | en |